购物车摘要

购物车里还没有商品。

SG-55

SKU: orb3211209

描述

SG-55 is a selective, non-competitive, orally active inhibitor of AKR1C3, with an IC50 of 5 nM and a Ki of 10 nM. It has over 2000-fold higher selectivity for AKR1C3 compared to AKR1C1, AKR1C2, and AKR1C4 (>10 μM). SG-55 enhances the NADPH/NADP+ ratio, decreases the GSH/GSSG ratio, and induces DNA double-strand breaks. Additionally, SG-55 can overcome resistance to Osimertinib mediated by the EGFRC797S triple mutation in non-small cell lung cancer (NSCLC).

图片与验证

−

关键属性

−
靶点Reductase

储存与操作

−
储存-20°C
有效期12 months from date of receipt.
免责声明For research use only
质量保证

质量保证

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our 条款与条件和选购指南.

实验方案信息

可选规格

请在下方选择规格

10 mg
50 mg